70 results
424B5
CRNX
Crinetics Pharmaceuticals, Inc.
21 Jun 24
Prospectus supplement for primary offering
6:11pm
by or on behalf of us or to which we have referred you. We and the selling securityholders take no responsibility for, and can provide no assurance … of customers in bearer form or registered in “street name.” Those payments will be the responsibility of participants and not of DTC or us, subject
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals, Inc.
21 Jun 24
Other Events
5:24pm
forth in this Section 1 on the amount of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company
S-3ASR
CRNX
Crinetics Pharmaceuticals, Inc.
21 Jun 24
Automatic shelf registration
4:45pm
securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We … will be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals, Inc.
3 Jun 24
Regulation FD Disclosure
4:35pm
during four wash-out days. The study is ongoing and aims to enroll 18 people.
The content in this release is the sole responsibility of Crinetics
S-3ASR
ujeoamxp
19 Mar 24
Automatic shelf registration
4:05pm
8-K
EX-1.1
bzjto7nkzupm0 anf
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
424B5
9m5ljhvsy8 qk
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
o20ilw 1zu3w5a
11 Sep 23
Prospectus supplement for primary offering
4:09pm
424B5
2h43s1lhrl6vmxq8mtd
12 Aug 22
Prospectus supplement for primary offering
8:31am
8-K
EX-1.1
u4m4mv3is15h4w1k
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
424B5
t8nrcxrz9h4qyjjm
13 Apr 22
Prospectus supplement for primary offering
4:22pm